PharmaCyte Biotech Cash from Investing (TTM) Analysis

PharmaCyte Biotech Inc (PMCB)

2.11 -0.01 (-0.47%) USD | NASDAQ | May 08, 16:00

2.11 0.00 (0.00%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2004. Upgrade now.

Date	Value
January 31, 2024	-5.00M
October 31, 2023	0.00
July 31, 2023	0.00
April 30, 2023	0.00
January 31, 2023	0.00
October 31, 2022	0.00
July 31, 2022	0.00
April 30, 2022	0.00
January 31, 2022	0.00
October 31, 2021	0.00
July 31, 2021	0.00
April 30, 2021	0.00
January 31, 2021	0.00
October 31, 2020	0.00
July 31, 2020	0.00
April 30, 2020	0.00
January 31, 2020	0.00
October 31, 2019	0.00
July 31, 2019	0.00
April 30, 2019	0.00
January 31, 2019	0.00
October 31, 2018	0.00
July 31, 2018	0.00
April 30, 2018	0.00
January 31, 2018	0.00

Date	Value
October 31, 2017
July 31, 2017
April 30, 2017
January 31, 2017
October 31, 2016
July 31, 2016	0.00
April 30, 2016	0.00
January 31, 2016	0.00
October 31, 2015
July 31, 2015
April 30, 2015
January 31, 2015
October 31, 2014	-1.008M
July 31, 2014	-1.990M
April 30, 2014	-3.559M
January 31, 2014	-2.716M
October 31, 2013	-2.876M
July 31, 2013	-2.020M
April 30, 2013	-0.6468M
January 31, 2013	-0.6735M
October 31, 2012	-0.6335M
July 31, 2012	-0.7475M
April 30, 2012	-0.8717M
January 31, 2012	-0.68M
October 31, 2011	-0.56M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-5.00M

Minimum

Jan 2024

Maximum

Jul 2019

-0.2632M

Average

Median